Green asthma inhaler put to the test in global study
NCT ID NCT07301736
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 28 times
Summary
This study compares a new version of an asthma inhaler that uses a more environmentally friendly propellant to the current inhaler. Researchers want to make sure both versions work equally well for people with mild to moderate asthma. About 780 adults will participate in this phase 2 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Elpida Trials - Parloes Hub
RECRUITINGDagenham, RM9 5QP, United Kingdom
Contact
Conditions
Explore the condition pages connected to this study.